Cargando…
2691. Does Janus Kinase Inhibitor Increase the Risk of Herpes Zoster in Rheumatoid Arthritis Patients in Saudi Arabia? A Multicenter Retrospective Cohort Study
BACKGROUND: JAK inhibitors (JAKi) are targeted synthetic disease-modifying antirheumatic drugs. Current evidence showed they are effective in either post Conventional or Biologic disease-modifying anti-rheumatic drugs ( cDMARDs) (bDMARDs) in patients with moderate to severe rheumatoid arthritis (RA)...
Autores principales: | Ahmed, Fida, Kaki, Reham, Abudaowd, Ola, Attar, Suzan, Almoallim, Hani, Salama, Gamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678830/ http://dx.doi.org/10.1093/ofid/ofad500.2302 |
Ejemplares similares
-
Rheumatoid arthritis in Saudi Arabia
por: Almoallim, Hani M., et al.
Publicado: (2014) -
Achieving comprehensive remission or low disease activity in rheumatoid patients and its impact on workability – Saudi Rheumatoid Arthritis Registry
por: Almoallim, Hani, et al.
Publicado: (2019) -
Pleuropulmonary manifestation in patients with rheumatoid arthritis in Saudi Arabia
por: Alamoudi, Omer S. B., et al.
Publicado: (2017) -
Public Knowledge, Attitude, and Practice Toward Herpes Zoster Vaccination in Saudi Arabia
por: Alleft, Lujain A, et al.
Publicado: (2023) -
Hyperlipidemia in rheumatoid arthritis patients in Saudi Arabia: Correlation with C-reactive protein levels and disease activity
por: Attar, Suzan M.
Publicado: (2015)